Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
501. |
ECCT/24/09/03 | WHO PPT vs DPEP FOR STI IN MSM WHO-Recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya. |
Principal Investigator(s) 1. Susan Graham 2. Fredrick Otieno 3. Joshua Kimani Site(s) in Kenya 1. Pwani Research Centre, in collaboration with two local community-based organisations (the HIV and AIDS People Alliance of Kenya [HAPA Kenya] and the International Centre for Reproductive Health [ICRH]) (Mombasa county) 2. Anza Mapema Clinic (Kisumu county) 3. Sex Workers Outreach Programme Clinic (Nairobi City county) |
View |
502. |
ECCT/14/12/01 | Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) in Latin America, EMEA and Asia |
Principal Investigator(s) 1. Anne Njeri Mugera Njambi Mugera 2. Dr. Martin N Wanyoike Njoroge Wanyoike 3. Charles Muthui Kariuki Muthui Kariuki 4. FEROZ ALI Allibhoy Site(s) in Kenya 1. Primecare Heart Clinic (Nairobi City county) 2. Dr. Silversteins Clinic (Nairobi City county) 3. Nairobi Cardiovascular Clinic (Nairobi City county) 4. Agah Khan Kisumu (Kisumu county) |
View |
503. |
ECCT/13/04/02 | XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study |
Principal Investigator(s) 1. Dr Charles Muthui Kariuki Site(s) in Kenya Nairobi Cardiovascular Clinic |
View |
504. |
ECCT/14/03/02 | Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation XANTUS-EL, Xarelto on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation - a non interventional study, XA 1206 (IMPACT No. 16691) |
Principal Investigator(s) 1. Warshow Majid Mbarak Site(s) in Kenya 1. MP Shah Hospital (Nairobi City county) |
View |
505. |
ECCT/22/11/04 | YWF:03 YWF:03: A PHASE III, MULTICENTER, DOUBLE BLIND, RANDOMIZED STUDY OF SII YELLOW FEVER VACCINE TO COMPARE SAFETY AND IMMUNOGENICITY WITH STAMARIL® |
Principal Investigator(s) 1. Videlis Nduba 2. Otieno Walter Site(s) in Kenya 1. KEMRI-CRDR (Nairobi City county) 2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county) |
View |